ArticlePlastic and reconstructive surgery. Global open2026
The Use of Extracellular Matrix in the Complex Reconstruction of the Lower Leg After Massive Avulsion.
Article in Plastic and reconstructive surgery. Global open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We present here the case of a 30-year-old patient with severe avulsion injuries who had a successful reconstruction with extracellular matrix (ECM), split-thickness skin graft (STSG), and vacuum-assisted closure therapy, highlighting the benefits of these innovative treatments in complex trauma care. Avulsion injuries caused by trauma result in the tearing of soft tissues (skin and subcutaneous tissue) with exposed neurovascular structures, tendons, muscles, and bone, and pose a major challenge for surgical treatment. Conventional methods often include necrectomy and primary closure, STSG, and local or distant (free) flaps. The new approaches we propose include the use of ECM with STSG and vacuum-assisted closure therapy, which offered promising results: shorter surgical time, faster recovery and healing, equal or better aesthetic and functional outcome, and no loss of function in the donor area. The ECM acts as a biocompatible scaffold that promotes cell migration and tissue regeneration, which is crucial for wound healing.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.